Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients

Brett C. Norman; David A. Jacobsohn; Kirsten M. Williams; Brandon K.C. Au; Margaret A. Au; S. J. Lee; Carina Moravec; Jason W. Chien

doi:10.1038/bmt.2010.311

Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients

Brett C. Norman(University of Washington), David A. Jacobsohn(Northwestern University), Kirsten M. Williams(National Institutes of Health), Brandon K.C. Au(University of Hawaiʻi at Mānoa), Margaret A. Au(University of Hawaiʻi at Mānoa), S. J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carina Moravec(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jason W. Chien(Fred Hutch Cancer Center)

Bone Marrow Transplantation

December 6, 2010

10.1038/bmt.2010.311

Cited by 82Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis